Detalhe da pesquisa
1.
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.
Blood;
140(12): 1378-1389, 2022 09 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35737911
2.
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
Br J Haematol;
194(2): 378-381, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34002365
3.
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Hematol Oncol;
39(3): 293-303, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33742718
4.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv;
7(14): 3764-3774, 2023 07 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37058477
5.
Targeted Locus Amplification as Marker Screening Approach to Detect Immunoglobulin (IG) Translocations in B-Cell Non-Hodgkin Lymphomas.
Methods Mol Biol;
2453: 119-132, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35622324
6.
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation.
Diagnostics (Basel);
11(5)2021 Apr 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33926007
7.
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis.
Sci Rep;
7(1): 17626, 2017 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29247244
8.
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network.
Hemasphere;
5(10): e639, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34514343